郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors.

期刊：Pharmacological research发表年份：2020作者：Gemma Navarro; Katia Varani; Alejandro Lillo; Fabrizio Vincenzi; Rafael Rivas-Santisteban; Iu Raïch; Irene Reyes-Resina; Carlos Ferreiro-Vera; Pier Andrea Borea; Verónica Sánchez de Medina; Xavier Nadal; Rafael Franco
阅读更多 →

药效评价A20 enhances mu-opioid receptor function by inhibiting beta-arrestin2 recruitment.

期刊：Biochemical and biophysical research communications发表年份：2020作者：Shuai Shao; Yi Sun; Yijia Zhang; Xiangyun Tian; Yulei Li; Bo Tan; Ruibin Su
阅读更多 →

药效评价Facile generation of monoclonal antibodies suitable for conjugation.

期刊：Journal of immunological methods发表年份：2020作者：K B Bjerrum; J B Aagaard; J A Soucy; A A Kabiljagic; K Skjoedt; J H Graversen; M L Henriksen; S W K Hansen
阅读更多 →

药效评价Nanodisc scaffold peptide (NSPr) replaces detergent by reconstituting acyl-CoA:cholesterol acyltransferase 1 into peptidiscs.

期刊：Archives of biochemistry and biophysics发表年份：2020作者：Bryan Neumann; Kevin Chao; Catherine C Y Chang; Ta-Yuan Chang
阅读更多 →